What are the treatment and prophylaxis options for migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Migraine Treatment and Prophylaxis

Acute Treatment

For most migraine sufferers, NSAIDs are first-line therapy, with aspirin, ibuprofen, or naproxen sodium showing the most consistent evidence. 1

First-Line Acute Treatment Algorithm

  • Start with NSAIDs (aspirin, ibuprofen, naproxen sodium) or the combination of acetaminophen plus aspirin plus caffeine for initial attacks 1
  • Acetaminophen alone has no evidence for efficacy and should not be used 1
  • Treat early in the attack to maximize effectiveness 1

Second-Line: Migraine-Specific Agents

  • If NSAIDs fail, escalate to triptans or DHE 1
  • Evidence-based triptans include: oral sumatriptan, rizatriptan, zolmitriptan, and naratriptan; subcutaneous sumatriptan; and DHE nasal spray 1
  • If one triptan fails, try another triptan or combine an NSAID with a triptan 1
  • Sumatriptan works through 5-HT1B/1D receptor agonism, causing cranial vessel constriction and inhibiting pro-inflammatory neuropeptide release 2

Special Considerations for Acute Treatment

  • Use non-oral routes (nasal spray, subcutaneous) when nausea or vomiting presents early 1
  • Add antiemetics for nausea even without vomiting, as nausea itself is disabling 1
  • Avoid opioids and butalbital-containing compounds except as absolute last resort due to risk of medication overuse headache 3

Emergency/Intractable Migraine

  • IV metoclopramide 10 mg plus IV ketorolac 30 mg is the most effective parenteral combination for severe migraine requiring emergency treatment 3

Prophylactic Treatment

Preventive therapy should be initiated when patients have ≥2 attacks per month producing disability lasting ≥3 days, or when acute medications are used more than twice weekly. 1

Indications for Prophylaxis

  • Two or more disabling attacks per month lasting ≥3 days 1
  • Contraindication to or failure of acute treatments 1
  • Use of abortive medication more than twice per week 1
  • Uncommon migraine conditions (hemiplegic migraine, prolonged aura, migrainous infarction) 1

First-Line Prophylactic Agents

Beta-blockers (propranolol 80-240 mg/d, timolol 20-30 mg/d, metoprolol, atenolol, bisoprolol), topiramate, or candesartan are first-line options. 1

  • Propranolol: 80-240 mg/d 1
  • Timolol: 20-30 mg/d 1
  • Topiramate: dose titrated to effect 1
  • Candesartan: evidence-based alternative 1

Second-Line Prophylactic Agents

  • Amitriptyline 30-150 mg/d 1
  • Flunarizine (where available) 1
  • Divalproex sodium 500-1500 mg/d or sodium valproate 800-1500 mg/d 1
    • Strictly contraindicated in women of childbearing potential due to teratogenic effects 1
    • If used, patients must use effective birth control and take folate 1

Third-Line: CGRP Monoclonal Antibodies

  • Erenumab, fremanezumab, galcanezumab, and eptinezumab are FDA-approved for migraine prevention 1
  • Reserved for patients who have failed other preventive drugs or have contraindications 1
  • Assess efficacy only after 3-6 months of treatment 1

Chronic Migraine (≥15 headache days/month)

  • OnabotulinumtoxinA 155 units is the only FDA-approved therapy specifically for chronic migraine prophylaxis 1, 3
  • Assess efficacy after 6-9 months 1
  • Topiramate has proven efficacy in randomized controlled trials for chronic migraine 1

Treatment Principles and Monitoring

Dosing and Duration

  • Start with low doses and titrate slowly to minimize adverse effects 1
  • Allow 2-3 months to assess efficacy of oral preventive medications before declaring failure 1, 3
  • Consider pausing preventive therapy after 6-12 months of successful treatment to determine if it can be discontinued 1

Medication Overuse Headache

  • Rule out medication overuse headache if acute medications are used >2 days per week 3
  • This creates a vicious cycle requiring withdrawal rather than escalation 3
  • Excessive acute medication intake is itself a strong indication for preventive therapy 1

Patient Education and Monitoring

  • Use headache diaries to track attack frequency, severity, duration, disability, and medication response 1
  • Educate patients that preventive therapy efficacy takes weeks to months 1
  • Calculate percentage reduction in monthly migraine days to quantify success 1

Non-Pharmacological Approaches

  • Cognitive-behavioral therapy (CBT) and biofeedback have evidence for efficacy 1, 3
  • Exercise (40 minutes three times weekly) is as effective as topiramate or relaxation therapy 3
  • Non-invasive neuromodulatory devices have supporting evidence 1
  • Acupuncture may be beneficial, though not superior to sham acupuncture 1
  • Little to no evidence exists for physical therapy, spinal manipulation, or dietary approaches 1

Special Populations

Children and Adolescents

  • Ibuprofen is first-line for acute treatment 1
  • In adolescents, consider sumatriptan/naproxen oral, zolmitriptan nasal, sumatriptan nasal, rizatriptan ODT, or almotriptan oral 1
  • Discuss with families that placebo was as effective as studied medications in many pediatric preventive trials 1
  • Consider amitriptyline combined with CBT, topiramate, or propranolol for prevention 1

Pregnancy and Breastfeeding

  • Discuss maternal disability versus fetal/neonatal risks when considering pharmacologic treatment 3
  • Many standard prophylactic agents have contraindications or require careful risk-benefit analysis 3

Common Pitfalls

  • Failure of one preventive class does not predict failure of others (except when due to poor adherence) 1
  • Poor adherence is common; simplified once-daily dosing improves compliance 1
  • Avoid escalating treatment without first ruling out medication overuse headache 3
  • Do not abandon preventive therapy prematurely—efficacy requires adequate trial duration 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Intractable Migraine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.